Ovulation Clinical Trial
Official title:
Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation
This study will examine the performance of the Persona assays in identifying the time when risk of pregnancy is highest by comparing results to ultrasound observed ovulation and other indices of ovulation.
Persona is a CE marked, natural method of contraception that works by monitoring hormone
changes in a woman's urine to identify the days of her menstrual cycle when she is likely to
become pregnant following unprotected intercourse. Persona consists of test sticks that
measure luteinising hormone (LH) and estrone-3-glucuronide (E3G), which are read by a
handheld monitor. This hormonal data is converted using a proprietary algorithm, into
simple-to-understand information on the user's contraceptive status; a "red light" where she
needs to abstain from intercourse to avoid pregnancy, or a "green light" where unprotected
intercourse is unlikely to lead to pregnancy. A prospective 13 cycle reliability study has
found Persona to be 94% effective.
This study will examine the relationship between the information provided by the Persona
assays and ultrasound observed ovulation, along with other indicators of when a woman is
fertile (basal body temperature (BBT) measurement and cervical secretion observations).
This is a single centre clinical study which will be conducted at the green-ivf clinic in
Grevenbroich, Germany. The primary objective will be to assess the difference between the
timing of the LH surge detected by Persona and observed ovulation by reference to
transvaginal ultrasound examination.
In addition, comparison of Persona determined levels of LH and E3G will be made to urine and
serum levels of these and other reproductive hormones. Comparison will also be made to BBT
and cervical secretion observations which are indirect measurements of the fertile phase.
In order to achieve these objectives, a minimum of 40 female volunteers will be recruited by
the study site either out of the patient pool coming for routine gynaecological examination
or from the general population via newspaper advertisement.
The study will last for one menstrual cycle starting on the first day of menstrual bleeding
(day 1 of the cycle) and concluding with the onset of the next menses. Volunteers will be
asked to collect daily urine samples and use an adapted Persona monitor for the duration of
the study as per the first cycle of use (i.e. a maximum of 16 tests). The monitor will be
adapted to blind the user from the result of each test. Volunteers will therefore be advised
that the modified Persona monitor cannot be used as a contraceptive device during the study.
Volunteers will also be asked to take daily measurements of BBT and to record this along
with cervical secretion observations on a daily natural family planning (NFP) chart.
Volunteers will be required to attend for a recruitment visit to the trial site followed by
approximately 12 visits either daily, or two days apart. Transvaginal ultrasonography will
be carried out on cycle days 5, 7, 9, 11 and daily from 16mm follicular size onwards until
ovulation has occurred. Blood sampling will also be conducted on these days as well as on
day 7 and day 9 post-ovulation.
Ultrasound examinations, blood sampling and hormonal blood tests will be performed at the
trial centre. Urine samples will be shipped to the study sponsor for hormonal analysis.
Diary and scan data will also be transferred to the study sponsor to provide a single data
set for analysis.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01129245 -
The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation
|
N/A | |
Completed |
NCT03778099 -
The Effect of Cinnamon on Ovulation Induction in Women With Polycystic Ovary Syndrome
|
Phase 3 | |
Completed |
NCT00796133 -
A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women
|
Phase 2 | |
Recruiting |
NCT04196595 -
Apple Women's Health Study
|
||
Completed |
NCT05448378 -
Evaluation of D-chiro-inositol Treatments
|
N/A | |
Recruiting |
NCT06142097 -
Sensor Technology Assessments of Reproductive Target Study
|
||
Completed |
NCT04382001 -
Heart Rate Variability During the Menstrual Cycle
|
||
Recruiting |
NCT05999123 -
Menstrual Cycle Study
|
||
Completed |
NCT04008277 -
Investigation of Heart Rate Variability During the Menstrual Cycle
|
||
Recruiting |
NCT02571543 -
Can Ibuprofen Delay Ovulation in Natural Cycle-IVF?
|
Phase 2 | |
Completed |
NCT00254189 -
Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
|
Phase 2 | |
Suspended |
NCT03106454 -
Ovulation Incidence in Oral Contraceptive Users
|
Phase 3 |